Welcome to our dedicated page for AMPHENOL /DE/ SEC filings (Ticker: APH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMPHENOL /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMPHENOL /DE/'s regulatory disclosures and financial reporting.
Michael R. Ivas, Amphenol Corporation's VP & Corporate Controller, reported an option exercise and an immediate sale of the resulting shares on 08/08/2025. He exercised 50,000 stock options at an exercise price of $18.23 and acquired 50,000 Class A shares, then sold 50,000 Class A shares at a weighted average sale price of $110.0164 (executed in multiple trades between $110.00 and $110.08). After these transactions the filing shows 152,412 shares beneficially owned directly by the reporting person and 0 stock options remaining. The filing also lists indirect holdings of 2,995 shares by children and 1,700 shares by spouse. The report documents conversion/exercise activity and a contemporaneous sale, reducing derivative holdings to zero while leaving a material direct ownership stake.
Amphenol Corporation (APH) filed a Form 144 reporting a proposed Rule 144 sale of 113,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $12,462,837.80 and 1,220,921,111 shares outstanding. The filing shows these shares were acquired on 08/11/2025 by exercise of options under a registered plan and payment was made in cash on the same date.
The filing also lists recent sales by the named seller, William Doherty: 113,000 shares sold on 08/08/2025 for $12,304,750.80 and 160,000 shares sold on 05/30/2025 for $14,326,512.00, totaling 273,000 shares and $26,631,262.80 in gross proceeds during the past three months. The notice includes the seller's representation that no undisclosed material adverse information exists.
Amphenol Corporation (APH) filed a Form 144 reporting a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $5,500,820.00. The filing states the company has 1,220,921,111 shares outstanding and lists the approximate date of sale as 08/08/2025. The shares were reported acquired the same day by exercise of options under a registered plan and paid for in cash. The notice also discloses a prior sale of 40,000 shares on 05/29/2025 for gross proceeds of $3,551,408.00. The filer affirms they do not possess undisclosed material adverse information.
Amphenol Corporation (APH) Form 144 notice reports a proposed sale of 113,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $12,304,750.80 and an approximate sale date of 08/08/2025. The shares were acquired on 08/08/2025 by exercising options under a registered plan and were to be paid in cash. The filing records total shares outstanding of 1,220,921,111 for the issuer. The document also discloses a prior sale of 160,000 shares on 05/30/2025 that generated gross proceeds of $14,326,512.00. The seller affirms no knowledge of undisclosed material adverse information.